Glaukos Corporation Announces Fourth Quarter and Full Year 2017 Financial Results

by Business Wire • 2018/02/28 • 0 Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the fourth quarter and full year ended December 31, 2017. Key highlights include: Achieved 26% net sales growth to $41.7 million in the fourth quarter of 2017, compared to $33.2 million in the fourth quarter o

← Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update and 2018 Guidance

Eye Changes May Signal Cognitive Decline →

Post navigation